Latest Breaking News On - Tony hickson - Page 1 : comparemela.com

Cancer Research UK and Guardant Health Launch Collaboration to Advance Cancer Research and Clinical Development Activities

Mission-focused collaboration to explore opportunities to help accelerate the discovery and development of cancer drugs and diagnostics for patients .

United kingdomTony hicksonHelmy eltoukhyGuardant healthCancer research unitedCancer research horizonsCentre for drug developmentCancer research united kingdomOur centre for drug developmentGuardant health incCancer research united kingdom fundedDrug developmentChief business officerCancer researchGuardant revealResearch united kingdom

Cancer Research UK and Guardant collaborate to advance cancer detection and treatment

Cancer Research UK and Guardant collaborate to advance cancer detection and treatment
pmlive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pmlive.com Daily Mail and Mail on Sunday newspapers.

United kingdomTony hicksonHelmy eltoukhyCancer research horizonCancer research horizonsDutch societyCentre for drug developmentCancer research united kingdomGuardant healthDrug developmentCancer research

Belfast s Sonrai Analytics joins forces with Cancer Research Horizons in pursuit of new precision medicines to treat cancer patients

Belfast s Sonrai Analytics joins forces with Cancer Research Horizons in pursuit of new precision medicines to treat cancer patients
newsletter.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newsletter.co.uk Daily Mail and Mail on Sunday newspapers.

United kingdomDarragh mcartTony hicksonCancer research horizonsCancer research united kingdomSonrai analyticsResearch horizonsSonrai discoveryCancer research

Imperial College London spin-out raises further investment for cell therapy targeting ovarian cancer

Imperial startup NK:IO has raised an additional £1.2m, in a funding round led by Cancer Research Horizons, the innovation arm of Cancer Research UK.NK:IO, a new Imperial startup developing a cell therapy for treating solid tumour cancers, has raised

United kingdomBrijesh royTony hicksonHugh jm bradyIain mcneishMatthew fuchterImperial college enterprise fundsImperial college enterprise fundDepartment of life sciencesDepartment of chemistryCancer research united kingdomOvarian cancer action research centre at imperialHead of the cancer divisionDepartment of surgeryUnited kingdom innovation science seed fundCancer research horizons

NK:IO raises £1 2 million to advance pioneering NK cell therapy

NK:IO, a leader in natural killer (NK) cell biology applied to the development of potent, off-the-shelf cell therapies targeting solid tumors, has raised £1.2m.

United kingdomHugh bradyMatt fuchterTony hicksonImperial college enterprise fundImperial collegeCancer research horizonsCancer research united kingdomUnited kingdom innovation science seed fundInnovate united kingdom new cancer therapeuticsInnovate united kingdom acceleratorStart codonUnited kingdom innovationScience seed fundGene therapy catapultInnovate united kingdom